Cann American Corp
Cann American Corp. is a development stage company dedicated to advancing healthcare solutions through innovative therapies. The company focuses on making healthcare affordable and accessible. By leveraging cutting-edge technology, the company aims to reduce costs and improve the availability of high-quality healthcare services for all patients. The company was formerly known as Canamed4Pets, Inc… Read more
Cann American Corp (CNNA) - Net Assets
Latest net assets as of August 2020: $165.84 USD
Based on the latest financial reports, Cann American Corp (CNNA) has net assets worth $165.84 USD as of August 2020.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($174.50) and total liabilities ($8.66). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $165.84 |
| % of Total Assets | 95.04% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | -100.25% |
| Growth Volatility | 5779.54 |
Cann American Corp - Net Assets Trend (2008–2023)
This chart illustrates how Cann American Corp's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Cann American Corp (2008–2023)
The table below shows the annual net assets of Cann American Corp from 2008 to 2023.
| Year | Net Assets | Change |
|---|---|---|
| 2023-02-28 | $-2.81K | +57.72% |
| 2022-02-28 | $-6.65K | -15558.13% |
| 2020-02-29 | $42.99 | +638.05% |
| 2019-02-28 | $-7.99 | -1498.00% |
| 2018-02-28 | $-0.50 | -100.00% |
| 2015-02-28 | $33.73K | -93.68% |
| 2014-02-28 | $533.73K | +4.54% |
| 2013-02-28 | $510.57K | -46.12% |
| 2012-02-29 | $947.64K | -16.30% |
| 2011-02-28 | $1.13 Million | +8546.87% |
| 2010-02-28 | $-13.40K | -1291.90% |
| 2009-02-28 | $-963.00 | -248.91% |
| 2008-02-29 | $-276.00 | -- |
Equity Component Analysis
This analysis shows how different components contribute to Cann American Corp's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 2170800.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (February 2023)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $947.09 | % |
| Other Components | $4.61K | % |
| Total Equity | $-2.81K | 100.00% |
Cann American Corp Competitors by Market Cap
The table below lists competitors of Cann American Corp ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Triad Pro Innovators Inc
PINK:TPII
|
$38.81 |
|
United Rail Inc
PINK:URAL
|
$39.15 |
|
ABC TRANSPORT PLC
XNSA:ABCTRANS
|
$39.17 |
|
Agri-Dynamics Inc
PINK:AGDY
|
$39.23 |
|
Osmotica Pharmaceuticals plc
BE:O1P
|
$38.50 |
|
FTN COCOA PROCESSORS PLC
XNSA:FTNCOCOA
|
$38.40 |
|
Gresham House Renewable Energy VCT 1 plc
LSE:GV1O
|
$38.36 |
|
RKRWF
PINK:RKRWF
|
$38.31 |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Cann American Corp's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2022 to 2023, total equity changed from -6,645 to -2,810, a change of 3,835.
- Net income of 3,821 contributed positively to equity growth.
- Other factors increased equity by 14.
Equity Change Factors (2022 to 2023)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $3.82K | +135.98% |
| Other Changes | $14.00 | +0.5% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Cann American Corp's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2008-02-29 | $-0.07 | $0.00 | x |
| 2009-02-28 | $-0.43 | $0.00 | x |
| 2010-02-28 | $-4.12 | $0.00 | x |
| 2011-02-28 | $357.84 | $0.00 | x |
| 2012-02-29 | $393.05 | $0.00 | x |
| 2018-02-28 | $0.00 | $0.00 | x |
| 2019-02-28 | $0.00 | $0.00 | x |
| 2020-02-29 | $0.00 | $0.00 | x |
| 2022-02-28 | $-0.03 | $0.00 | x |
| 2023-02-28 | $-0.01 | $0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Cann American Corp utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-76.05%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2008 | 0.00% | 0.00% | 0.00x | 0.00x | $-11.90K |
| 2009 | 0.00% | 0.00% | 0.00x | 0.00x | $-46.59K |
| 2010 | 0.00% | 0.00% | 0.00x | 0.00x | $-11.10K |
| 2011 | -4.01% | 0.00% | 0.00x | 1.06x | $-158.60K |
| 2012 | -27.92% | 0.00% | 0.00x | 1.26x | $-359.34K |
| 2013 | -269.10% | 0.00% | 0.00x | 1.80x | $-1.42 Million |
| 2014 | -32.34% | 0.00% | 0.00x | 1.72x | $-225.86K |
| 2018 | 0.00% | -1.95% | 0.13x | 0.00x | $-0.45 |
| 2019 | 0.00% | -6.42% | 0.60x | 0.00x | $-6.69 |
| 2020 | -579.20% | -954.02% | 0.55x | 1.10x | $-253.30 |
| 2022 | 0.00% | 0.00% | 0.00x | 0.00x | $11.21K |
| 2023 | 0.00% | 0.00% | 0.00x | 0.00x | $4.10K |
Industry Comparison
This section compares Cann American Corp's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $548,450,613
- Average return on equity (ROE) among peers: -450.37%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Cann American Corp (CNNA) | $165.84 | 0.00% | 0.05x | $38.62 |
| Ascend Wellness Holdings Inc (AAWH) | $142.87 Million | -33.75% | 5.44x | $48.90 Million |
| AB Science S.A (ABSCF) | $10.73 Million | -252.65% | 3.71x | $39.89 Million |
| Alterola Biotech Inc (ABTI) | $4.85K | -2005.32% | 0.49x | $603.58K |
| Aurora Cannabis Inc (ACB) | $2.04 Billion | -34.08% | 0.34x | $199.15 Million |
| Acreage Holdings Inc (ACRDF) | $204.27 Million | -30.85% | 1.41x | $13.48K |
| Acura Pharmaceuticals Inc (ACUR) | $7.90 Million | -63.15% | 1.15x | $13.20K |
| Agra Ventures Ltd. (AGFAF) | $1.51 Million | -44.22% | 0.06x | $298.23K |
| Allergy Therapeutics plc (AGYTF) | $2.07 Million | -2084.75% | 31.32x | $25.30 Million |
| Aida Pharmaceuticals Inc (AIDA) | $6.67 Million | 24.51% | 2.78x | $1.80 |
| Adcock Ingram Holdings Limited (AIHLF) | $3.07 Billion | 20.55% | 0.55x | $85.61 Million |